inflammation as a major contributor to airflow limitation. In the concept of neurogenic inflammation, neural mediators are considered to contribute to the inflammatory microenvironment responsible for the airflow limitation that causes chronic pulmonary symptoms. [4] [5] [6] [7] Vagal afferent nerves in the lung play a significant role in modulating airway tone, with the bronchopulmonary sensory C-fibres being of particular importance. [8] [9] [10] [11] These C-fibres are very sensitive to various endogenous inflammatory mediators and inhaled irritants. [8] [9] [10] Both vagal control and afferent sensory C-fibres have been demonstrated to play key roles in antigen-induced bronchoconstriction in sensitized animals [12] [13] [14] ; however, the involvement of the parasympathetic pathway during the sensitization period has not been characterized.
Thus, the aim of the present study was to characterize the general involvement of the cholinergic neural pathway in the development of BHR during allergen exposure. An earlier report suggesting that acute inhibition of the parasympathetic pathway before allergen challenge increased pulmonary inflation pressure 15 led us to hypothesize that blockade of the parasympathetic pathway by blocking muscarinic receptors during allergen sensitization may modulate lung responsiveness to the specific allergen. In addition, to reveal the relative contributions of the central and peripheral lung to adverse allergeninduced changes in lung function, we assessed airway and tissue responses separately by using the forced oscillation technique (FOT).
| RE SULTS
The present study was performed on 40 rats divided into five groups: a vehicle control group (C, n = 8), two groups receiving intraperitoneal injections of ovalbumin (OVA) with (S, n = 7) or without atropine (O, n = 9) and a final two groups receiving repeated OVA aerosol either alone (OA, n = 7) or combined with atropine (SA, n = 9).
| End-expiratory lung volume
The results of end-expiratory lung volume (EELV) measurements normalized against bodyweight are shown in Figure 1 . There were no differences in EELV between Days 0 and 21 within Groups C, O and S as evaluated by two-way repeated measures analysis of variance (ANOVA). However, in groups receiving atropine (Groups OA and SA), there was a significant increase in EELV on Day 21 compared with Day 0 (P = 0.02 and P = 0.01, respectively).
| Methacholine challenge
Respiratory mechanical changes in response to methacholine per minute) increases in Raw and G, the MCh-induced increases in respiratory tissue elastance (H) were mild but significant (P < 0.05).
On Day 0, there were no significant differences between groups in Raw, G and H responses to all MCh concentrations tested. On F I G U R E 1 End-expiratory lung volume normalized to bodyweight in the protocol groups measured before ( , Day 0) and after ( , Day 21) the sensitization protocol with or without atropine treatment (left) and the relative changes between the two experimental days (right 
| Ovalbumin challenge
Temporal changes in respiratory mechanical parameters in response to OVA are shown in Figure 3 . Two-way repeated measures ANOVA revealed significant interactions between group allocation and OVA-induced Raw, G and H responses (P < 0.001, P < 0.001 and P < 0.05, respectively), indicating that the treatments affected lung responsiveness to OVA. According to post hoc analyses, there were no significant changes in any parameters peak percentage Raw responses in these groups of 62 ± 18% and 63 ± 34%, respectively, compared with 11.9 ± 4.2% in Group C; these differences did not differ significantly because of considerable interindividual variability (P = 0.12). However, marked and sustained OVA-induced increases in Raw were observed in both atropine-treated groups, with peak Raw changes of 657 ± 245% and 177 ± 47% in Groups OA and SA, respectively (P < 0.05 vs Group C). Significant increases were seen in G and H 2, 3 and 4 minutes after OVA challenge in all OVA-treated groups (P < 0.05 for all), whereas corresponding increases in G and H were detected earlier and lasted longer in Groups S, OA and SA.
| Bronchoalveolar lavage
After the 3-week treatment period, the total number of cells in the bronchoalveolar lavage fluid (BALF) differed between groups: sensitization with OVA aerosols (Groups S and SA) resulted in increased accumulation of inflammatory cells in the bronchoalveolar space ( Figure 4a ; P < 0.001, one-way ANOVA test on ranks). Regarding differential cell counts in the BALF, significant neutrophil accumulation was observed at the expense of macrophages in OVA aerosol-treated rats (Groups S and SA; P < 0.05; Figure 4b ). There was a tendency for an increase in the relative number of eosinophils in Groups S, OA and SA as compared to Group C, but the difference did not reach statistical significance (P = 0.078).
| D ISCUSS I ON
The present study investigates the involvement of the cholinergic pathway during allergic airway sensitization. The results demonstrate that inhibition of the parasympathetic nervous system during the sensitization period augments lung responsiveness to the specific allergen. These enhanced responses were manifested more markedly in mechanical changes, reflecting constriction of the main conducting airways, and, to a lesser extent, in mechanical indices characterizing respiratory tissue mechanics. This exacerbation was striking in rats systemically exposed to the allergen, whereas repeated inhalation of the allergen after systemic sensitization blunted the intensified mechanical responses to the allergen. The excessive responses in respiratory mechanical parameters in rats with parasympathetic nerve blockade were associated with significant increases in the normalized static lung volume.
| Baseline measurements
There were no differences in basal airway or respiratory tissue mechanical parameters between the different groups. These findings are in agreement with previous reports of the lack of effect of OVA sensitization and atropine on baseline respiratory mechanics. [16] [17] [18] However, in the present study there was an increase in static lung volume in atropine-treated rats. This may be a consequence of the direct effect of atropine on EELV, which is in line with a previous report indicating that loss of parasympathetic control in humans leads to increased functional residual capacity.
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F I G U R E 3 Changes in airway resistance (Raw) and in tissue damping (G) and elastance (H) in response to the specific allergen (ovalbumin). *, #, $, § and + denote statistically significant differences relative to the baseline (BL) in Groups ( ) C, ( ) O, ( ) S, ( ) OA and ( ) SA, respectively. α and x denote statistically significant difference relative to Groups C and OA, respectively, within a condition
| Responses to a non-specific cholinergic agonist
The aim of the constrictor challenge with MCh was to evaluate how sensitization with OVA and prolonged atropine pretreatment affect the lung response to a non-specific cholinergic agonist. In the present study, repeated OVA aerosol exposure generated chronic airway inflammation, manifested as the accumulation of neutrophils and a tendency for an increase in the number of eosinophils. These results are in agreement with previous studies in which similar sensitization protocols were used. 15, 20 However, despite these cellular changes, there was no evidence of altered lung responsiveness to
MCh. Following sensitization with aerosolized OVA, the coexistence of bronchial inflammation and the lack of BHR to non-specific constrictor challenge are controversial, but our findings are in accordance with results indicating dissociated inflammatory and mechanical responses. 15, 21, 22 Surprisingly, prolonged atropine treatment throughout the experimental period blunted, but did not abolish, the respiratory mechanical changes resulting from intravenous infusion of MCh.
Detailed analyses of the responses in individual rats revealed that only two rats in Groups OA and SA responded to MCh in a similar way to rats that did not receive atropine, whereas all other rats (n = 5 each in Groups OA and SA) did not respond to MCh at all.
These observations suggest that although the subcutaneously implanted pumps provided sufficient atropine to most rats to maintain general muscarinic receptor blockade, the pumps may have suffered a technical failure by the time of the second set of experiments in two rats from each of these group. However, the lack of weight gain in these outlier rats (data not shown) suggests that continuous atropine administration led to a hypermetabolic state in these two rats. Nevertheless, the concentration of atropine in the circulation may not have been sufficient to block responses to MCh by Day 21, when the second set of experiments was performed. Therefore, we included these animals in data analyses, bearing in mind this potential drawback for the other findings.
| Responses to the specific allergen
In agreement with previous results, 20, 23 intravenous injection of the specific allergen in sensitized rats led to the development of bronchoconstriction via various mediators involved in immune and inflammatory responses. The lack of a difference in mechanical responses between Groups S and O may be attributed to the greater importance of topical administration of the allergen during the sensitization period rather than its systemic delivery. This finding is in accordance with previous results demonstrating no differences in immune responses following local and systemic administration, 24 and revealing no need for a systemic adjuvant to induce airway inflammation. 25 The main finding of the present study is the significant exacerbation of the anaphylactic lung constrictor response in rats treated with atropine throughout the sensitization period. This effect was somewhat diminished, but still significant, in rats that were exposed repeatedly to aerosolized OVA. This blunted response may be at- 
| Limitations
A limitation inherent in the present study is related to differences in airway innervation between different species. 32 This variability affects the density and distribution of pre-and post-ganglionic nerve fibres, as well as the expression of nicotinic and muscarinic receptor subtypes. In addition to these anatomical differences, functional dissimilarities can also be anticipated because rat bronchi synthesize and store substantially more of the main cholinergic neurotransmitter acetylcholine than human airways. 32 These factors warrant consideration before extrapolating the findings of the present study to human lung diseases.
| CON CLUS IONS
The present study characterizes the potential role of the choliner- 
| ME THODS

| Sensitization and protocol groups
The experimental protocol was approved by the Experimental Ethics
Committee of the University of Geneva and the Animal Welfare
Committee of the Canton of Geneva, Switzerland. Brown Norway rats (Janvier SAS, Le Genest-Saint-Isle, France), 13 weeks old, were used in the experiments. The animals were housed in a chamber with artificial light for 12 hours/day. Food and water were available ad libitum.
The rats were randomly assigned to one of five protocol groups Under general anaesthesia, the pump was introduced under the dorsal skin into the back side of the animal, below the thoracic region.
| Anaesthesia and surgical preparations
On Day 0, the rats were anaesthetized with an intraperitoneal injection of chloral hydrate (5%, 400 mg/kg; Sigma-Aldrich) to allow spontaneous breathing during measurement of EELV. 35 To measure respiratory mechanics with the FOT (see below), the rats were then Monitor for small animals, Holliston, MA, USA) was applied to maintain the temperature in the normal range (37 ± 0.5°C).
| Experimental protocol
The experimental protocol was designed to study EELV and MCh On Day 21, the same experimental procedure was repeated by re-establishing the baseline EELV and respiratory mechanics, together with a repeated assessment of the MCh responsiveness.
Bilateral vagotomy was then performed in the mid-cervical region.
A second provocation challenge with the specific allergen OVA was then performed (2 mg iv). 36 Three forced oscillatory recordings were collected at baseline, and individual oscillatory impedance data were then measured at 30-second intervals after the injection of the allergen for 7 minutes or until a systemic hemodynamic collapse (mean systemic blood pressure reaching ~30 mm Hg). Finally, BALF was collected for the assessment of bronchial inflammation.
| Measurements
| End-expiratory lung volume
To assess EELV, the rats were placed in a supine position in a sealed Plexiglas chamber (2.8 L) and were ventilated at a PEEP of 2.5 cmH 2 O, as detailed previously. 37 The Boyle's law. 37 For an exact comparison, the EELV data obtained on Days 0 and 21 were normalized to the bodyweights of the animals.
| Respiratory mechanics
Forced oscillation technique was applied to assess the contributions of the airway and tissue mechanical properties to the total respiratory resistance, as detailed previously. 38, 39 Briefly, the mechanical impedance of the respiratory system (Zrs) was measured during short apnoeic periods while the tracheal cannula was connected from the respirator to a loudspeaker-in-box system at end-expiration. To assess the changes in the airway and tissue mechanical properties separately, a mathematical model containing a frequencyindependent airway resistance (Raw) and inertance (Iaw) connected to a constant-phase tissue compartment, 40 including damping (G) and elastance (H), was fitted to the Zrs spectra by minimizing the differences between the measured and modelled impedance values:
where j is the imaginary unit, ω is the angular frequency (2πf), and α = 2/π arctan(H/G). It has been established that the Raw parameter is primarily related to the overall airway geometry, as the contribution of the chest wall to the frequency-independent Newtonian resistance is minor. 41 The parameters G and H reflect the energy losses (damping or resistance) and the energy storage (stiffness or elastance) of the total respiratory system, respectively. 
| Bronchoalveolar lavage fluid
To evaluate the inflammatory lung response, we analysed the BALF.
At the end of the second experiment, the trachea of the rat was con- When the hydrostatic filling reached a volume of 10 mL, the BALF was retained. The total number of cells in the BALF was counted by using a Neubauer chamber.
The BALF was centrifuged in a 2 mL Eppendorf tube (750 rpm for 7 minutes). The supernatant was removed, and the pellet was resuspended in an adequate quantity of PBS 42 to obtain a concentration of 10 4 cells/100 μL. For cytological evaluation, a cytospin was performed with 100 μL of the suspended cells. The slides were fixed and stained with May-Grünwald-Giemsa solution (Sigma-Aldrich).
Slices were scanned with a Mirax system (3DHistech, Budapest, Hungary). A collaborator who was uninformed of the experimental protocol manually counted a selected area inside the spot (with a Panoramic Viewer; 3DHistech) and discriminated the following cell types: eosinophil, macrophage, polymorphonuclear and lymphocyte. The total number of cells in the spot area was obtained by multiplying these counts by the total surface area.
| Statistical analyses
Data are presented as means ± SEM. The Shapiro-Wilk test was used to test data for normality, data were normalized by using a logarithmic OA and SA), were used to evaluate the effects of treatments on lung responsiveness to the bronchoconstrictor provocation. Holm-Sidak tests were used for post hoc analyses. Data obtained from the BALF were not normally distributed, these data were analysed by using one-way ANOVA on ranks. P < 0.05 was considered statistically significant.
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